REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,145,934 | -67.5% | 274,275 | -28.3% | 0.00% | -50.0% |
| Q2 2023 | $9,687,605 | +267070.6% | 382,758 | +240.0% | 0.00% | +100.0% |
| Q1 2023 | $3,626 | -60.5% | 112,567 | -77.4% | 0.00% | -60.0% |
| Q4 2022 | $9,190 | -99.9% | 497,829 | +82.6% | 0.01% | +25.0% |
| Q3 2022 | $7,359,000 | +13.3% | 272,583 | -42.0% | 0.00% | 0.0% |
| Q2 2022 | $6,497,000 | +149.6% | 470,124 | +252.2% | 0.00% | +300.0% |
| Q1 2022 | $2,603,000 | +350.3% | 133,479 | +543.2% | 0.00% | – |
| Q3 2021 | $578,000 | +7.2% | 20,751 | +7.5% | 0.00% | – |
| Q1 2021 | $539,000 | -86.8% | 19,298 | -86.6% | 0.00% | -100.0% |
| Q4 2020 | $4,081,000 | +548.8% | 144,005 | +476.0% | 0.00% | +200.0% |
| Q3 2020 | $629,000 | -64.5% | 25,000 | -77.1% | 0.00% | -50.0% |
| Q4 2019 | $1,772,000 | +246.1% | 109,199 | +177.2% | 0.00% | +100.0% |
| Q3 2019 | $512,000 | +4.3% | 39,400 | +26.5% | 0.00% | 0.0% |
| Q1 2019 | $491,000 | -93.8% | 31,158 | -92.0% | 0.00% | -91.7% |
| Q4 2018 | $7,882,000 | -49.7% | 391,549 | -37.9% | 0.01% | -36.8% |
| Q3 2018 | $15,672,000 | -47.3% | 630,656 | -41.8% | 0.02% | -51.3% |
| Q2 2018 | $29,744,000 | -35.4% | 1,083,574 | -27.5% | 0.04% | -36.1% |
| Q1 2018 | $46,029,000 | -6.7% | 1,494,441 | +8.3% | 0.06% | -10.3% |
| Q4 2017 | $49,329,000 | +10600.4% | 1,379,832 | +7797.8% | 0.07% | +6700.0% |
| Q2 2017 | $461,000 | -2.3% | 17,471 | -23.1% | 0.00% | 0.0% |
| Q1 2017 | $472,000 | -54.8% | 22,705 | -55.0% | 0.00% | -50.0% |
| Q4 2016 | $1,045,000 | -35.7% | 50,502 | -45.8% | 0.00% | -50.0% |
| Q1 2016 | $1,626,000 | -59.6% | 93,115 | -21.0% | 0.00% | -50.0% |
| Q4 2015 | $4,026,000 | -23.5% | 117,850 | -33.3% | 0.01% | -20.0% |
| Q3 2015 | $5,262,000 | -37.3% | 176,801 | -32.7% | 0.01% | -37.5% |
| Q2 2015 | $8,398,000 | +1938.3% | 262,609 | +1220.3% | 0.02% | +1500.0% |
| Q1 2015 | $412,000 | -71.9% | 19,890 | -77.0% | 0.00% | -66.7% |
| Q4 2014 | $1,466,000 | -50.8% | 86,552 | -43.8% | 0.00% | -62.5% |
| Q3 2014 | $2,977,000 | -27.3% | 153,984 | +27.8% | 0.01% | -27.3% |
| Q2 2014 | $4,096,000 | -59.5% | 120,473 | -62.5% | 0.01% | -62.1% |
| Q1 2014 | $10,114,000 | – | 321,082 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |